TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Center for Research in Implementation Science and Prevention (CRISP): Project 1: Comparative Effectiveness Trial of Two Reminder/Recall Methods to Increase Immunization Rates in Young Children
Brief Summary: The purpose of this study is to determine if a collaborative centralized population-based reminder/recall intervention is more effective than a traditional practice-based reminder/recall intervention at increasing immunizations among young children.


Options:
A: Arm Label: General health information; Type: PLACEBO_COMPARATOR; Interventions: Other: general health information | Arm Label: Influenza and general health information; Type: ACTIVE_COMPARATOR; Interventions: Other: influenza and general health information | Intervention Type: OTHER; Name: influenza and general health information; Assigned to Arm(s): Influenza and general health information | Intervention Type: OTHER; Name: general health information; Assigned to Arm(s): General health information
B: Arm Label: General Adolescent Vaccine Brochure; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: General Adolescent Vaccine Brochure | Arm Label: HPV brochure, recall, reminders; Type: EXPERIMENTAL; Interventions: Behavioral: HPV brochure, recall, reminders | Intervention Type: BEHAVIORAL; Name: HPV brochure, recall, reminders; Assigned to Arm(s): HPV brochure, recall, reminders | Intervention Type: BEHAVIORAL; Name: General Adolescent Vaccine Brochure; Assigned to Arm(s): General Adolescent Vaccine Brochure
C: Arm Label: No reminder / recall notice; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mailed reminder / recall notice; Type: EXPERIMENTAL; Interventions: Behavioral: Childhood vaccination reminder / recall notification | Intervention Type: BEHAVIORAL; Name: Childhood vaccination reminder / recall notification; Assigned to Arm(s): mailed reminder / recall notice
D: Arm Label: Collaborative Population-Based Recall-Phone/Mail Group; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Pop-Based R/R: Phone/Mail Group | Arm Label: Collaborative Population-Based Recall-Mail Only Group; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative Pop-Based R/R: Mail-Only Group | Arm Label: Practice-based Recall; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Practice-based Recall | Intervention Type: BEHAVIORAL; Name: Collaborative Pop-Based R/R: Phone/Mail Group; Assigned to Arm(s): Collaborative Population-Based Recall-Phone/Mail Group | Intervention Type: BEHAVIORAL; Name: Collaborative Pop-Based R/R: Mail-Only Group; Assigned to Arm(s): Collaborative Population-Based Recall-Mail Only Group | Intervention Type: BEHAVIORAL; Name: Practice-based Recall; Assigned to Arm(s): Practice-based Recall

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet Treatment for Social Phobia in Romania: A Randomized Controlled Trial
Brief Summary: The main aim of this study is to investigate the effectiveness of an Internet-delivered intervention for social phobia by comparing it to a waitlist control group. The second aim of the study is to track the potential changes in participants' thinking patterns. Because this is among the first guided Internet-delivered interventions conducted in Romania, the treatment credibility will also be investigated. Finally, the predictive power of anxiety sensitivity for both SAD symptoms and the treatment effectiveness will be investigated.


Options:
A: Arm Label: Smartphone-supplemented iCBT with therapist support; Type: EXPERIMENTAL; Interventions: Behavioral: Smartphone-supplemented iCBT, Behavioral: Therapist support | Arm Label: Smartphone-supplemented iCBT without therapist support; Type: EXPERIMENTAL; Interventions: Behavioral: Smartphone-supplemented iCBT | Arm Label: Active waiting list control group with delayed treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smartphone-supplemented iCBT, Other: Active waiting list | Intervention Type: BEHAVIORAL; Name: Smartphone-supplemented iCBT; Assigned to Arm(s): Active waiting list control group with delayed treatment, Smartphone-supplemented iCBT with therapist support, Smartphone-supplemented iCBT without therapist support | Intervention Type: BEHAVIORAL; Name: Therapist support; Assigned to Arm(s): Smartphone-supplemented iCBT with therapist support | Intervention Type: OTHER; Name: Active waiting list; Assigned to Arm(s): Active waiting list control group with delayed treatment
B: Arm Label: Tailored Internet-delivered CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Internet-administrated CBT-Treatment | Arm Label: Waitlist; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Waitlist | Intervention Type: BEHAVIORAL; Name: Tailored Internet-administrated CBT-Treatment; Assigned to Arm(s): Tailored Internet-delivered CBT | Intervention Type: BEHAVIORAL; Name: Waitlist; Assigned to Arm(s): Waitlist
C: Arm Label: iSOFIE; Type: EXPERIMENTAL; Interventions: Other: iSOFIE | Arm Label: Waitlist control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: iSOFIE; Assigned to Arm(s): iSOFIE
D: Arm Label: Internet-based CBT; Type: N/A; Interventions: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Internet Treatment for Social Phobia in Romania: A Randomized Controlled Trial
Brief Summary: The main aim of this study is to investigate the effectiveness of an Internet-delivered intervention for social phobia by comparing it to a waitlist control group. The second aim of the study is to track the potential changes in participants' thinking patterns. Because this is among the first guided Internet-delivered interventions conducted in Romania, the treatment credibility will also be investigated. Finally, the predictive power of anxiety sensitivity for both SAD symptoms and the treatment effectiveness will be investigated.


Options:
A: Arm Label: iSOFIE; Type: EXPERIMENTAL; Interventions: Other: iSOFIE | Arm Label: Waitlist control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: iSOFIE; Assigned to Arm(s): iSOFIE
B: Arm Label: tailored internet-administrated CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Internet-administrated CBT-Treatment | Arm Label: waitlist; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Waitlist | Intervention Type: BEHAVIORAL; Name: Tailored Internet-administrated CBT-Treatment; Assigned to Arm(s): tailored internet-administrated CBT | Intervention Type: BEHAVIORAL; Name: Waitlist; Assigned to Arm(s): waitlist
C: Arm Label: Internet CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-based cognitive behavior therapy (CBT). | Arm Label: Group CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Group CBT | Intervention Type: BEHAVIORAL; Name: Internet-based cognitive behavior therapy (CBT).; Assigned to Arm(s): Internet CBT | Intervention Type: BEHAVIORAL; Name: Group CBT; Assigned to Arm(s): Group CBT
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Internet-delivered CBT. | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: On line discussion group | Intervention Type: BEHAVIORAL; Name: Internet-delivered CBT.; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: On line discussion group; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Follicular Flushing on Cycle Outcomes in Poor Responders
Brief Summary: Patients with infertility often undergo in vitro fertilization (IVF) to achieve a pregnancy, which involves ovarian stimulation, monitoring of follicular growth, oocyte retrieval, sperm insemination, embryo culture and embryo transfer.

The oocytes are removed during surgery by aspirating the follicles using a single lumen needle with an ultrasound to guide the procedure. There is some data that flushing the follicles with embryo culture media before aspiration using a double lumen needle increases the number of oocytes retrieved, particularly among poor responding patients for whom each additional oocyte recovered may substantially alter the outcome of that IVF cycle.

The objective of the research is to evaluate the effect of follicular flushing in poor responders on IVF cycle outcomes.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Patients receiving short protocol IVF/ICSI-treatment. | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Long protocol | Intervention Type: DRUG; Name: Patients receiving short protocol IVF/ICSI-treatment.; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Long protocol; Assigned to Arm(s): 2
B: Arm Label: Follicular flushing; Type: ACTIVE_COMPARATOR; Interventions: Other: Aspiration without flushing follicles with culture media, Other: Follicular Flushing | Intervention Type: OTHER; Name: Aspiration without flushing follicles with culture media; Assigned to Arm(s): Follicular flushing | Intervention Type: OTHER; Name: Follicular Flushing; Assigned to Arm(s): Follicular flushing
C: Arm Label: SL1(Cook® Single Lumen); Type: ACTIVE_COMPARATOR; Interventions: Device: Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)" | Arm Label: DL1 (Cook® EchoTip® Double Lumen); Type: ACTIVE_COMPARATOR; Interventions: Device: Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)" | Intervention Type: DEVICE; Name: Oocyte retrieval with only aspiration system "SL1(Cook® Single Lumen)"; Assigned to Arm(s): SL1(Cook® Single Lumen) | Intervention Type: DEVICE; Name: Oocyte retrieval with aspiration and flushing system "DL1 (Cook® EchoTip® Double Lumen)"; Assigned to Arm(s): DL1 (Cook® EchoTip® Double Lumen)
D: Arm Label: follicular flushing group; Type: EXPERIMENTAL; Interventions: Other: follicular flushing | Arm Label: aspiration group; Type: ACTIVE_COMPARATOR; Interventions: Other: no follicular flushing | Intervention Type: OTHER; Name: follicular flushing; Assigned to Arm(s): follicular flushing group | Intervention Type: OTHER; Name: no follicular flushing; Assigned to Arm(s): aspiration group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Drug Eluting Balloon in peripherAl inTErvention For Below The Knee Angioplasty Evaluation: the DEBATE-BTK Study
Brief Summary: Drug-eluting balloon showed positive results in terms of restenosis reduction in peripheral intervention (PTA). The aim of the study is to investigate in a randomized fashion the efficacy and safety of Paclitaxel-eluting balloon (PEB) (In.Pact Amphirion, Invatec, Brescia, Italy) versus non drug-eluting balloon (NEB) (Amphirion deep, Invatec, Brescia, Italy) in diabetic patients with Critical Limb Ischemia (CLI) undergoing PTA of below-the-knee (BTK) vessels.


Options:
A: Arm Label: Stent; Type: EXPERIMENTAL; Interventions: Device: Zilver® PTX™ Stent | Intervention Type: DEVICE; Name: Zilver® PTX™ Stent; Assigned to Arm(s): Stent
B: Arm Label: Passeo-18 Lux DRB; Type: EXPERIMENTAL; Interventions: Device: Passeo-18 Lux DRB | Arm Label: Standard PTA (POBA); Type: ACTIVE_COMPARATOR; Interventions: Device: Standard PTA (POBA) | Intervention Type: DEVICE; Name: Passeo-18 Lux DRB; Assigned to Arm(s): Passeo-18 Lux DRB | Intervention Type: DEVICE; Name: Standard PTA (POBA); Assigned to Arm(s): Standard PTA (POBA)
C: Arm Label: Drug Coated Balloon (DCB) Arm; Type: EXPERIMENTAL; Interventions: Procedure: Paclitaxel coated balloon angioplasty. | Arm Label: Drug Eluting Stents (DES) Arm; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Infrapopliteal Primary Drug Eluting Stenting | Intervention Type: PROCEDURE; Name: Paclitaxel coated balloon angioplasty.; Assigned to Arm(s): Drug Coated Balloon (DCB) Arm | Intervention Type: PROCEDURE; Name: Infrapopliteal Primary Drug Eluting Stenting; Assigned to Arm(s): Drug Eluting Stents (DES) Arm
D: Arm Label: standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: POBA | Arm Label: Drug-eluting balloon angioplasty; Type: EXPERIMENTAL; Interventions: Device: PEB | Intervention Type: DEVICE; Name: PEB; Assigned to Arm(s): Drug-eluting balloon angioplasty | Intervention Type: DEVICE; Name: POBA; Assigned to Arm(s): standard PTA

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Drug Eluting Balloon in peripherAl inTErvention for In-Stent Restenosis: the DEBATE-ISR Study
Brief Summary: The purpose of this study is to evaluate the efficacy of drug-eluting balloon angioplasty followed versus conventional balloon angioplasty in superficial femoral artery and popliteal artery re-stenosis.


Options:
A: Arm Label: DEB; Type: N/A; Interventions: Device: DEB | Arm Label: conventional PTA; Type: N/A; Interventions: Device: POBA | Intervention Type: DEVICE; Name: DEB; Assigned to Arm(s): DEB | Intervention Type: DEVICE; Name: POBA; Assigned to Arm(s): conventional PTA
B: Arm Label: standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: nitinol stent implantation | Arm Label: DEB; Type: EXPERIMENTAL; Interventions: Device: paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation | Intervention Type: DEVICE; Name: paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation; Assigned to Arm(s): DEB | Intervention Type: DEVICE; Name: nitinol stent implantation; Assigned to Arm(s): standard PTA
C: Arm Label: Moxy Drug Coated Balloon; Type: EXPERIMENTAL; Interventions: Device: Moxy Drug Coated Balloon | Arm Label: Standard Uncoated Angioplasty Balloon; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Uncoated Angioplasty Balloon | Intervention Type: PROCEDURE; Name: Standard Uncoated Angioplasty Balloon; Assigned to Arm(s): Standard Uncoated Angioplasty Balloon | Intervention Type: DEVICE; Name: Moxy Drug Coated Balloon; Assigned to Arm(s): Moxy Drug Coated Balloon
D: Arm Label: Drug-Coated Balloon (DCB); Type: EXPERIMENTAL; Interventions: Device: Drug-Coated Balloon (DCB) | Arm Label: Standard PTA; Type: ACTIVE_COMPARATOR; Interventions: Device: PTA Balloon: Balloon Angioplasty | Intervention Type: DEVICE; Name: Drug-Coated Balloon (DCB); Assigned to Arm(s): Drug-Coated Balloon (DCB) | Intervention Type: DEVICE; Name: PTA Balloon: Balloon Angioplasty; Assigned to Arm(s): Standard PTA

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Drug Eluting Balloon in peripherAl inTErvention for In-Stent Restenosis: the DEBATE-ISR Study
Brief Summary: The purpose of this study is to evaluate the efficacy of drug-eluting balloon angioplasty followed versus conventional balloon angioplasty in superficial femoral artery and popliteal artery re-stenosis.


Options:
A: Arm Label: Laser atherectomy and PTA; Type: EXPERIMENTAL; Interventions: Device: Turbo Elite Laser and Turbo Tandem Laser Guide Catheters | Arm Label: Balloon angioplasty; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Balloon angioplasty | Intervention Type: DEVICE; Name: Turbo Elite Laser and Turbo Tandem Laser Guide Catheters; Assigned to Arm(s): Laser atherectomy and PTA | Intervention Type: PROCEDURE; Name: Balloon angioplasty; Assigned to Arm(s): Balloon angioplasty
B: Arm Label: Endoprosthesis; Type: EXPERIMENTAL; Interventions: Device: GORE VIABAHN® Endoprosthesis | Arm Label: Plain old balloon angioplasty; Type: ACTIVE_COMPARATOR; Interventions: Device: Plain old balloon angioplasty | Intervention Type: DEVICE; Name: GORE VIABAHN® Endoprosthesis; Assigned to Arm(s): Endoprosthesis | Intervention Type: DEVICE; Name: Plain old balloon angioplasty; Assigned to Arm(s): Plain old balloon angioplasty
C: Arm Label: Paclitaxel eluting balloon; Type: ACTIVE_COMPARATOR; Interventions: Device: drug eluting balloon angioplasty | Arm Label: Standard balloon angioplasty; Type: ACTIVE_COMPARATOR; Interventions: Device: standard balloon angioplasty | Intervention Type: DEVICE; Name: drug eluting balloon angioplasty; Assigned to Arm(s): Paclitaxel eluting balloon | Intervention Type: DEVICE; Name: standard balloon angioplasty; Assigned to Arm(s): Standard balloon angioplasty
D: Arm Label: DEB; Type: N/A; Interventions: Device: DEB | Arm Label: conventional PTA; Type: N/A; Interventions: Device: POBA | Intervention Type: DEVICE; Name: DEB; Assigned to Arm(s): DEB | Intervention Type: DEVICE; Name: POBA; Assigned to Arm(s): conventional PTA

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Comparison of the Effect of a Conjoint Analysis Based Values Clarification Exercise, Rating and Ranking Exercise, and Balance Sheet for Colorectal Cancer Screening and Prostate Cancer Screening Decision Making
Brief Summary: Participants will be recruited from the United States and Australia to take an online survey about colon cancer screening or prostate cancer screening. Individuals selected for both the prostate cancer survey and the colon cancer study will be randomized to take one of three survey types - balance sheet, rating and ranking or conjoint analysis. These surveys will help participants clarify their values and opinions about screening options for colon cancer or prostate cancer. Participants' responses to the online survey are measured at one point in time - the time at which the participant takes the survey.


Options:
A: Arm Label: Rating and Ranking Group; Type: OTHER; Interventions: Other: Rating and Ranking Task | Arm Label: Discrete Choice Group; Type: OTHER; Interventions: Other: Discrete Choice Task | Arm Label: Balance Sheet Group; Type: OTHER; Interventions: Other: Balance Sheet Task | Intervention Type: OTHER; Name: Rating and Ranking Task; Assigned to Arm(s): Rating and Ranking Group | Intervention Type: OTHER; Name: Discrete Choice Task; Assigned to Arm(s): Discrete Choice Group | Intervention Type: OTHER; Name: Balance Sheet Task; Assigned to Arm(s): Balance Sheet Group
B: Arm Label: ADAPT tool; Type: EXPERIMENTAL; Interventions: Behavioral: ADAPT tool | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ADAPT tool; Assigned to Arm(s): ADAPT tool
C: Arm Label: Chest Pain Choice Decision Aid; Type: ACTIVE_COMPARATOR; Interventions: Other: Chest Pain Choice Decision Aid | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Chest Pain Choice Decision Aid; Assigned to Arm(s): Chest Pain Choice Decision Aid
D: Arm Label: Personalized Risk Information; Type: ACTIVE_COMPARATOR; Interventions: Other: Personalized Heart Attack and Stroke Risk | Arm Label: Standard Education; Type: OTHER; Interventions: Other: Standard Education | Intervention Type: OTHER; Name: Personalized Heart Attack and Stroke Risk; Assigned to Arm(s): Personalized Risk Information | Intervention Type: OTHER; Name: Standard Education; Assigned to Arm(s): Standard Education

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cardiac Remote Ischemic Preconditioning Prior to Elective Major Vascular Surgery
Brief Summary: The investigators have previously shown that elective vascular surgery is a high-risk operation with an anticipated risk of either death or heart attack of 15%. This study is testing whether a protocol of remote ischemic preconditioning (RIPC) applied 24 hours prior to the operation is safe, feasible and reduces the incidence of an adverse, perioperative cardiac complication.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Procedure: clamping with pre-conditioning (PCl) | Arm Label: Arm 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: clamping with pre-conditioning (PCl); Assigned to Arm(s): Arm 1
B: Arm Label: Sham; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Control | Arm Label: RIPC; Type: EXPERIMENTAL; Interventions: Procedure: Preconditioning | Intervention Type: PROCEDURE; Name: Preconditioning; Assigned to Arm(s): RIPC | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Sham
C: Arm Label: Remote ischaemic preconditioning; Type: EXPERIMENTAL; Interventions: Procedure: Remote ischaemic preconditioning | Arm Label: Control to RIPC; Type: SHAM_COMPARATOR; Interventions: Procedure: Control to RIPC | Intervention Type: PROCEDURE; Name: Remote ischaemic preconditioning; Assigned to Arm(s): Remote ischaemic preconditioning | Intervention Type: PROCEDURE; Name: Control to RIPC; Assigned to Arm(s): Control to RIPC
D: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Remote ischaemic preconditioning | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Procedure: Control | Intervention Type: PROCEDURE; Name: Remote ischaemic preconditioning; Assigned to Arm(s): Intervention | Intervention Type: PROCEDURE; Name: Control; Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brain Morphometries in OA Patients Treated With Duloxetine
Brief Summary: This study aims to determine in people with knee Osteoarthritis (OA) if relief of pain after treatment with either duloxetine or placebo is associated with changes in brain anatomy.


Options:
A: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sugar pill | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Sugar pill; Assigned to Arm(s): Sugar pill
B: Intervention Type: DRUG; Name: duloxetine HCL; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A
C: Arm Label: Arm I/Group A (Duloxetine then Placebo); Type: EXPERIMENTAL; Interventions: Drug: duloxetine hydrochloride, Other: placebo | Arm Label: Arm II/Group B (Placebo then Duloxetine); Type: EXPERIMENTAL; Interventions: Drug: duloxetine hydrochloride, Other: placebo | Intervention Type: DRUG; Name: duloxetine hydrochloride; Assigned to Arm(s): Arm I/Group A (Duloxetine then Placebo), Arm II/Group B (Placebo then Duloxetine) | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Arm I/Group A (Duloxetine then Placebo), Arm II/Group B (Placebo then Duloxetine)
D: Intervention Type: DRUG; Name: Pregabalin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Amitriptyline; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Brain Morphometries in OA Patients Treated With Duloxetine
Brief Summary: This study aims to determine in people with knee Osteoarthritis (OA) if relief of pain after treatment with either duloxetine or placebo is associated with changes in brain anatomy.


Options:
A: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine, Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
B: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Sugar pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sugar pill | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Sugar pill; Assigned to Arm(s): Sugar pill
C: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Duloxetine; Type: EXPERIMENTAL; Interventions: Drug: Duloxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): Duloxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: B